Publication

Byline

Location

US Patent Issued to GENENTECH on Oct. 6 for "CDK inhibitors" (Chinese, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,951, issued on Oct. 6, was assigned to GENENTECH INC. (South San Francisco, Calif.). "CDK inhibitors" was invented by Zhilong Hu (Shanghai),... और पढ़ें


US Patent Issued to Zhejiang Hisun Pharmaceutical, Shanghai Aryl Pharmtech on Oct. 6 for "Quinazoline derivative, or preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,952, issued on Oct. 6, was assigned to Zhejiang Hisun Pharmaceutical Co. Ltd. (Taizhou, China) and Shanghai Aryl Pharmtech Co. Ltd. (Shanghai... और पढ़ें


US Patent Issued to Rheinische-Friedrich-Wilhelms-Universitat Bonn, Katholieke Universiteit Leuven KU Leuven Research & Development on Oct. 6 for "MRGX receptor antagonists" (Belgian, German Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,953, issued on Oct. 6, was assigned to Rheinische-Friedrich-Wilhelms-Universitat Bonn (Bonn, Germany) and Katholieke Universiteit Leuven KU L... और पढ़ें


US Patent Issued to Principia Biopharma on Oct. 6 for "Methods for treating drug and vaccine induced immune thrombocytopenia by administering specific compounds" (British, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,954, issued on Oct. 6, was assigned to Principia Biopharma Inc. (Morristown, N.J.). "Methods for treating drug and vaccine induced immune th... और पढ़ें


US Patent Issued to SHIONOGI & Co. on Oct. 6 for "Formulation for oral administration, comprising triazine derivative" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,955, issued on Oct. 6, was assigned to SHIONOGI & Co. LTD. (Osaka, Japan). "Formulation for oral administration, comprising triazine derivat... और पढ़ें


US Patent Issued to TransThera Sciences (Nanjing) on Oct. 6 for "Use of multikinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,957, issued on Oct. 6, was assigned to TransThera Sciences (Nanjing) Inc. (Nanjing, China). "Use of multikinase inhibitor" was invented by P... और पढ़ें


US Patent Issued to Laboratorios Silanes on Oct. 6 for "Combination drug for the control and management of type 2 diabetes mellitus" (Mexican Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,958, issued on Oct. 6, was assigned to Laboratorios Silanes S.A. de C.V. (Mexico City). "Combination drug for the control and management of ... और पढ़ें


US Patent Issued to University of Miami on Oct. 6 for "Cannabidiol nanodrug formulations and methods for use of the same" (Florida Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,959, issued on Oct. 6, was assigned to University of Miami (Miami). "Cannabidiol nanodrug formulations and methods for use of the same" was ... और पढ़ें


US Patent Issued to QUORUM BIO on Oct. 6 for "Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,961, issued on Oct. 6, was assigned to QUORUM BIO Co. LTD. (Seoul, South Korea). "Composition for prevention, amelioration, or treatment of ... और पढ़ें


US Patent Issued to Societe des Produits Nestle on Oct. 6 for "Compositions comprising human milk oligosaccharides for use in a subject to support maturation of sleeping patterns" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,962, issued on Oct. 6, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland). "Compositions comprising human milk oligosacch... और पढ़ें